All In Biotech

Drug Trial Radar · NCT06861088

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial Comparing, Relative to Placebo, the Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer (CATIQ P3)

Last checked: Nov 20, 2026Latest source record: Feb 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 480 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

480

Planned (sponsor's estimate)

Start

Dec 19, 2025

Primary completion

Oct 31, 2027

Study completion Oct 31, 2029

Sponsor

Lead sponsor
Quercis Pharma AGIndustry
Sponsor type
Industry
First posted
Mar 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally advanced pancreatic cancer.

Conditions

  • Venous Thromboembolism
  • Metastatic Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma

Interventions

  • Kinisoquin™Drug

    Kinisoquin™ capsules formulated with vitamin C and vitamin B3

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effectiveness of Kinisoquin™Time frame: 16 weeks
  2. Effectiveness of Kinisoquin™Time frame: 16 weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Ventura Clinical Trials

    Ventura, California · Recruiting

  • Clavis Medical, LLC

    Miami Lakes, Florida · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.